Influence of various factors on event-free survival after HSCT (multivariate analysis)
| Factor . | HR . | 95% CI . | P . |
|---|---|---|---|
| Age, 2 y or more vs 2 y or less | 1.07 | 0.66-1.74 | .80 |
| Donor group, URD vs MSD | 1.75 | 0.53-1.79 | .17 |
| Donor group, MMRD vs MSD | 2.54 | 1.38-4.50 | — |
| Autoimmunity, yes vs no | 1.05 | 0.62-1.83 | .85 |
| Splenectomy, yes vs no | 1.12 | 0.66-1.96 | .66 |
| Disease severity score, more than 4-5 vs 2-3 | 1.16 | 0.70-1.92 | .55 |
| cGVHD, yes vs no | 1.92 | 1.10-3.03 | .02 |
| Chimerism, mixed/split vs full | 1.90 | 1.26-2.79 | .003 |
| Factor . | HR . | 95% CI . | P . |
|---|---|---|---|
| Age, 2 y or more vs 2 y or less | 1.07 | 0.66-1.74 | .80 |
| Donor group, URD vs MSD | 1.75 | 0.53-1.79 | .17 |
| Donor group, MMRD vs MSD | 2.54 | 1.38-4.50 | — |
| Autoimmunity, yes vs no | 1.05 | 0.62-1.83 | .85 |
| Splenectomy, yes vs no | 1.12 | 0.66-1.96 | .66 |
| Disease severity score, more than 4-5 vs 2-3 | 1.16 | 0.70-1.92 | .55 |
| cGVHD, yes vs no | 1.92 | 1.10-3.03 | .02 |
| Chimerism, mixed/split vs full | 1.90 | 1.26-2.79 | .003 |
HR indicates hazard ratio.